Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Stock Catapults 81% Though Its Price And Business Still Lag The Industry
Earnings Preview: AMLX to Report Financial Results Pre-market on November 07
$Amylyx Pharmaceuticals(AMLX.US)$ is scheduled to release its financial results pre-market on November 07 ET. Earnings PreviewAnalysts estimate $Amylyx Pharmaceuticals(AMLX.US)$ to post revenue of
Amylyx Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024
BofA Securities Maintains Amylyx Pharmaceuticals(AMLX.US) With Buy Rating
Perceptive Advisors LLC's Strategic Acquisition in Amylyx Pharmaceuticals Inc
Amylyx Upgraded to Buy by BofA on Hypoglycemia Drug Potential
BofA Securities Upgrades Amylyx Pharmaceuticals(AMLX.US) to Buy Rating, Announces Target Price $10
Analysts Offer Insights on Healthcare Companies: Intra-Cellular Therapies (ITCI), Amylyx Pharmaceuticals Inc (AMLX) and Intuitive Surgical (ISRG)
Neutral Stance on Amylyx Pharmaceuticals Amid Promising Data and Uncertainties
We're Not Very Worried About Amylyx Pharmaceuticals' (NASDAQ:AMLX) Cash Burn Rate
Leerink Partners Maintains Amylyx Pharmaceuticals(AMLX.US) With Hold Rating, Announces Target Price $4
Express News | Amylyx Pharmaceuticals Inc Shares up 35.2% a T $5.29
Why Amylyx Pharmaceuticals Stock Was So Healthy This Week
H.C. Wainwright Maintains Amylyx Pharmaceuticals(AMLX.US) With Buy Rating, Maintains Target Price $8
HC Wainwright & Co. Reiterates Buy on Amylyx Pharma, Maintains $8 Price Target
Analysts' Top Healthcare Picks: Neumora Therapeutics, Inc. (NMRA), Amylyx Pharmaceuticals Inc (AMLX)
Amylyx Pharma Analyst Ratings
Amylyx Pharmaceuticals Reports Results From Pancreatic Disease Treatment Trial
Amylyx Pharmaceuticals Announces Positive Topline Results From Phase 2 HELIOS Clinical Trial Demonstrating Sustained Improvements With AMX0035 in People Living With Wolfram Syndrome
Express News | Amylyx Pharmaceuticals Inc - to Meet FDA for Phase 3 Program, Update Expected in 2025